282 related articles for article (PubMed ID: 26371051)
1. Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention.
Roth CL
J Clin Med; 2015 Sep; 4(9):1774-97. PubMed ID: 26371051
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic obesity in patients with craniopharyngioma: profound changes of several weight regulatory circuits.
Roth CL
Front Endocrinol (Lausanne); 2011; 2():49. PubMed ID: 22654811
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.
van Iersel L; Brokke KE; Adan RAH; Bulthuis LCM; van den Akker ELT; van Santen HM
Endocr Rev; 2019 Feb; 40(1):193-235. PubMed ID: 30247642
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic Obesity: Prologue and Promise.
Abuzzahab MJ; Roth CL; Shoemaker AH
Horm Res Paediatr; 2019; 91(2):128-136. PubMed ID: 30884480
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Acquired Hypothalamic Obesity: Now and the Future.
Dimitri P
Front Endocrinol (Lausanne); 2022; 13():846880. PubMed ID: 35464063
[TBL] [Abstract][Full Text] [Related]
6. Approach to the Patient With Hypothalamic Obesity.
Shoemaker AH; Tamaroff J
J Clin Endocrinol Metab; 2023 Apr; 108(5):1236-1242. PubMed ID: 36413492
[TBL] [Abstract][Full Text] [Related]
7. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity.
van Santen HM; Schouten-Meeteren AY; Serlie M; Meijneke RW; van Trotsenburg AS; Verberne H; Holleman F; Fliers E
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):53-7. PubMed ID: 25514327
[TBL] [Abstract][Full Text] [Related]
8. Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review.
Ni W; Shi X
World Neurosurg; 2018 Oct; 118():e59-e71. PubMed ID: 29945001
[TBL] [Abstract][Full Text] [Related]
9. Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity.
Roth CL; Eslamy H; Werny D; Elfers C; Shaffer ML; Pihoker C; Ojemann J; Dobyns WB
Obesity (Silver Spring); 2015 Jun; 23(6):1226-33. PubMed ID: 25884561
[TBL] [Abstract][Full Text] [Related]
10. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma.
Holmer H; Pozarek G; Wirfält E; Popovic V; Ekman B; Björk J; Erfurth EM
J Clin Endocrinol Metab; 2010 Dec; 95(12):5395-402. PubMed ID: 20826582
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis, Background, and Treatment of Hypothalamic Damage in Craniopharyngioma.
Erfurth EM
Neuroendocrinology; 2020; 110(9-10):767-779. PubMed ID: 32580186
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hypothalamic obesity in people with hypothalamic injury: new drugs are on the horizon.
Roth CL; Zenno A
Front Endocrinol (Lausanne); 2023; 14():1256514. PubMed ID: 37780616
[TBL] [Abstract][Full Text] [Related]
13. Studies of different female rat models of hypothalamic obesity.
Elfers C; Ralston M; Roth CL
J Pediatr Endocrinol Metab; 2011; 24(3-4):131-7. PubMed ID: 21648279
[TBL] [Abstract][Full Text] [Related]
14. Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans.
Lee M; Korner J
Pituitary; 2009; 12(2):87-95. PubMed ID: 18327643
[TBL] [Abstract][Full Text] [Related]
15. Leptin signaling, adiposity, and energy balance.
Jéquier E
Ann N Y Acad Sci; 2002 Jun; 967():379-88. PubMed ID: 12079865
[TBL] [Abstract][Full Text] [Related]
16. Could deep brain stimulation be a possible solution for acquired hypothalamic obesity?
Dassen AR; van Schaik J; van den Munckhof P; Schuurman PR; Hoving EW; van Santen HM
Heliyon; 2023 Mar; 9(3):e14411. PubMed ID: 36967879
[TBL] [Abstract][Full Text] [Related]
17. Alpha-Melanocyte-Stimulating Hormone is Elevated in Hypothalamic Obesity Associated with Childhood Craniopharyngioma.
Emet DC; Ozon A; Alikasifoglu A; Kandemir N; Gonc N
Obesity (Silver Spring); 2021 Feb; 29(2):402-408. PubMed ID: 33491320
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents.
Kim JH; Choi JH
Ann Pediatr Endocrinol Metab; 2013 Dec; 18(4):161-7. PubMed ID: 24904871
[TBL] [Abstract][Full Text] [Related]
19. [Hypothalamic dysfunction in obesity].
van de Sande-Lee S; Velloso LA
Arq Bras Endocrinol Metabol; 2012 Aug; 56(6):341-50. PubMed ID: 22990637
[TBL] [Abstract][Full Text] [Related]
20. Craniopharyngioma: long-term consequences of a chronic disease.
Müller HL
Expert Rev Neurother; 2015; 15(11):1241-4. PubMed ID: 26523617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
